After pricing controversy, EpiPen maker offers cheaper, generic version
August 29, 2016 at 10:05 AM EDT
Ed Adamczyk PITTSBURGH, Aug. 29 (UPI) -- Mylan N.V. announced a lower-cost generic version of the EpiPen after U.S. senators railed against the steep price increase to $500 last week.
